What you'll learn in this expert session
A new shingles vaccination makes it more important than ever that health practitioners are across all the options available to help prevent this painful disorder.
Shingles is now a common topic of conversation courtesy of a recent public awareness campaign. In this presentation, Prof Tony Cunningham will outline all the latest evidence and information in relation to Shingles, including details of the most recently available vaccine for this condition - its risks, benefits, advantages and disadvantages.
Learning Objectives:
- Describe the aetiology of Herpes Zoster (Shingles) disease
- Identify the symptoms and complications of Herpes Zoster disease
- Compare the live attenuated (Zostavax) with the adjuvanted recombinant (Shingrix) vaccines
- Relate the side-effects of the Shingrix in the immunocompetent and immunocompromised
About the Expert
Prof Tony Cunningham AO
Prof Anthony (Tony) Cunningham AO, FAHMS, MD, FRACP, FRCPA is an Infectious Diseases Physician, Clinical Virologist and Scientist. He is the past Director, Centre for Virus Research at The Westmead Institute for Medical Research (WIMR); Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2); and Professor in the Faculty of Medicine and Health at the University of Sydney.
Prof Cunningham is the lead author of the ‘Vaccines for COVID-19’ paper, commissioned from the Australian Academy of Health and Medical Sciences.
Course curriculum
-
1
How to complete this course
-
Instructions
-
-
2
An Update on Shingles Vaccination
-
Summary and learning objectives
-
Video lecture (25 mins)
-
Quiz: test your learning (10 mins)
-
-
3
Document your CPD here
-
CPD Documentation and Reflection Activity Tool
-
-
4
Feedback
-
Please let us know your thoughts
-